Vertex Pharmaceuticals Incorporated
Patents, Design & Utilities
Last updated:
List of all Vertex Pharmaceuticals Incorporated patents 160 in total
| Status | Patent |
|---|---|
Application | Utility: Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)Cyclopropanecarboxa- mide Filling date: 12 Sep 2025 Issue date: 5 Sep 2019 |
Grant | Utility: DNA-PK inhibitors Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 27 Aug 2019 |
Application | Utility: DNA-PK INHIBITORS Filling date: 12 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Filling date: 12 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators Filling date: 12 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS Filling date: 12 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Filling date: 12 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: GCN2 INHIBITORS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: GCN2 INHIBITORS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 1 Aug 2019 |
Showing 150 to 160 of 160 patents.